MedPath

cocaine hydrochloride nasal

These highlights do not include all the information needed to use  safely and effectively. See full prescribing information for . Cocaine Hydrochloride nasal solution, CII Initial U.S. Approval: 2017

Approved
Approval ID

4e3b2f6b-1b57-40bc-872b-01c0a3c7986e

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Sep 24, 2023

Manufacturers
FDA

OMNIVIUM PHARMACEUTICALS LLC.

DUNS: 117919347

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

cocaine hydrochloride nasal

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code81665-301
Application NumberNDA209575
Product Classification
M
Marketing Category
C73605
G
Generic Name
cocaine hydrochloride nasal
Product Specifications
Route of AdministrationTOPICAL
Effective DateSeptember 25, 2023
FDA Product Classification

INGREDIENTS (6)

COCAINE HYDROCHLORIDEActive
Quantity: 40 mg in 1 mL
Code: XH8T8T6WZH
Classification: ACTIB
CITRIC ACID MONOHYDRATEInactive
Code: 2968PHW8QP
Classification: IACT
SODIUM BENZOATEInactive
Code: OJ245FE5EU
Classification: IACT
D&C YELLOW NO. 10Inactive
Code: 35SW5USQ3G
Classification: IACT
FD&C GREEN NO. 3Inactive
Code: 3P3ONR6O1S
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

cocaine hydrochloride nasal - FDA Drug Approval Details